Size :50ug
Clone Number:
Aliases:CI 19KD antibody; CI PGIV antibody; CI-19kD antibody; CI-PGIV antibody; Complex I 19k antibody; Complex I 19kD antibody; Complex I PGIV antibody; Complex I PGIV subunit antibody; Complex I-19kD antibody; Complex I-PGIV antibody; MGC793 antibody; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 8 (19kD PGIV) antibody; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 8 19kDa antibody; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 8 antibody; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 antibody; NADH ubiquinone oxidoreductase 19 kDa subunit antibody; NADH ubiquinone oxidoreductase PGIV subunit antibody; NADH-ubiquinone oxidoreductase 19 kDa subunit antibody; NDUA8_HUMAN antibody; NDUFA 8 antibody; NDUFA8 antibody; OTTHUMP00000022034 antibody; PGIV antibody
Product Type:Polyclonal Antibody
Immunogen Species:Homo sapiens (Human)
UniProt ID:P51970
Immunogen:Synthesized peptide derived from the Internal region of Human NDUFA8.
Raised in:Rabbit
Species Reactivity:Human, Mouse
Tested Applications:WB, IHC, ELISA; WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:40000
Background:
Clonality:Polyclonal
Isotype:IgG
Purification Method:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Conjugate:Non-conjugated
Buffer:Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Form:Liquid
Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Names:NDUFA8
Research Areas:Cancer;Cell biology;Metabolism;Signal transduction